Contego Medical Announces European Commercialization of the Paladin® Carotid Post-Dilation Balloon with Integrated Embolic Protection(TM) Technology

Presenting at the Leipzig Interventional Course (LINC) from January 26(th)-29(th )in Leipzig, Germany.

RALEIGH, North Carolina, Jan. 14, 2016 /PRNewswire/ -- Contego Medical today announced the European commercialization of the Paladin® Carotid Post-Dilation Balloon, the first and only angioplasty balloon with Integrated Embolic Protection(TM) (IEP) Technology for patients undergoing carotid stenting procedures. The innovative IEP platform, which combines embolic protection and treatment into one device, is designed to simplify the procedure and improve patient outcomes.

"The Paladin System represents a significant development in embolic protection. In a single step I can post-dilate the carotid stent and capture smaller embolic debris using the 40-micron filter," commented Dr. Alberto Cremonesi, Director Interventional Cardio-Angiology, Villa Maria Cecilia Hospital, Cotignola, Italy. "I look forward to more broadly using the intuitive system in my practice."

The Paladin System improves outcomes by reducing the risk of embolization during post-dilation, when the patient has the highest risk of embolic events. The single-step system integrates a post-dilation balloon proximally and an embolic protection filter at the distal catheter tip. Prior to post-dilation, the physician deploys the adjustable 40-micron filter providing protection against both macro- and micro-embolic debris. The intuitive and versatile system enhances a physician's ability to treat carotid stenosis.

"The European launch of the Paladin System marks a major milestone for Contego," stated Dr. Ravish Sachar, Founder and CEO of Contego Medical. "After receiving approval in 2015 the European post market registry results have been very positive. We are excited to bring this treatment option to European physicians and patients."

The Paladin System will be presented and featured in live cases at LINC [] on Tuesday, January 26(th) during the Technical Forum session "Deep Dive Session: Carotid Revascularization []."

About Contego Medical Contego Medical, LLC, a privately held medical device company, has developed a portfolio of novel products to address unmet needs in the cardiovascular and peripheral vascular space. Contego's innovative solutions integrate filter-based embolic protection and treatment into a single device. Their product portfolio is poised to transform cardiovascular and endovascular intervention by making existing procedures safer without increasing complexity or compromising performance. Physicians Ravish Sachar MD and Jay Yadav MD, thought leaders and proven entrepreneurs, founded Contego in 2005.

Learn more at [].

Contego Medical, LLC

CONTACT: Paul Sanders, Chief Operating Officer, 888-708-7271,

Web site:

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234